STATISTICAL ANALYSIS OF 100 BREAST CANCER CASES WITH EVALUATION OF HER2/NEU STATUS IMMUNOHISTOCHEMISTRY CORRELATION WITH GENE AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION ASSAY

被引:0
|
作者
Sivakami [1 ]
Kannan, Indhu [1 ]
Madhusudhanan [1 ]
机构
[1] Meenakshi Mission Hosp & Res Ctr, Dept Pathol, Madurai, Tamil Nadu, India
来源
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS | 2018年 / 7卷 / 49期
关键词
Breast Cancer; Infiltrating Ductal Carcinoma (NOS) HER 2 Gene Immunohistochemistry Fluorescence; in Situ Hybridization;
D O I
10.14260/jemds/2018/1174
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Breast cancer has surpassed all other cancers in women becoming the leading cause for mortality. 100 breast cancer cases received in our department of pathology during the period 2016-2017 were evaluated for HER2/neu status and immunohistochemistry correlation with gene amplification by FISH assay. MATERIALS AND METHODS Mastectomy samples received were fixed followed by grossing including all parameters like laterality, size, margin status and adequate lymph node sampling. The tissue sections were stained with H&E for assessing the tumour type, grade, surgical margin clearance study. Lymph node involvement, oestrogen receptor and progesterone receptors Her2/neu was done with immunohistochemistry in the tumour blocks. Subsequently tissue blocks were also subjected to FISH evaluation for Her2/neu. RESULTS The tumour laterality, tumour categorization, staging, and grading were analysed. Comparison of immunohistochemical Her2 results with FISH was done. CONCLUSION Immunohistochemical analysis of Her2/neu with 0 and 1+ Negative. 3+ strong positive had a High concordance with FISH evaluation.
引用
收藏
页码:5298 / 5303
页数:6
相关论文
共 50 条
  • [21] Evaluation of HER2 Gene Amplification in Breast Cancer Using Nuclei Microarray in Situ Hybridization
    Jiang, Huiyong
    Bai, Xiaoyan
    Zhang, Cheng
    Zhang, Xuefeng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (05) : 5519 - 5527
  • [22] Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer
    Albina Stocker
    Andreas Trojan
    Constanze Elfgen
    Marie-Louis Hilbers
    Linda Moskovszky
    Zsuzsanna Varga
    Breast Cancer Research and Treatment, 2020, 183 : 311 - 319
  • [23] Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer
    Stocker, Albina
    Trojan, Andreas
    Elfgen, Constanze
    Hilbers, Marie-Louis
    Moskovszky, Linda
    Varga, Zsuzsanna
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (02) : 311 - 319
  • [24] HER-2/Neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer:: Implications for daily laboratory practice
    Larsimont, D
    Di Leo, A
    Rouas, G
    Paesmans, M
    Ferreira, F
    Bernard, C
    Cardoso, F
    Verhest, A
    Piccart, MJ
    Gancberg, D
    ANTICANCER RESEARCH, 2002, 22 (04) : 2485 - 2490
  • [25] Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancer
    Horii, Rie
    Matsuura, Masaaki
    Iwase, Takuji
    Ito, Yoshinori
    Akiyama, Futoshi
    BREAST CANCER, 2014, 21 (05) : 598 - 604
  • [26] Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancer
    Rie Horii
    Masaaki Matsuura
    Takuji Iwase
    Yoshinori Ito
    Futoshi Akiyama
    Breast Cancer, 2014, 21 : 598 - 604
  • [28] Correlation of HER2 gene status assessment by fluorescence in situ hybridization between histological sections and cytological specimens of breast cancer
    Rieko Nishimura
    Akihiro Kagawa
    Sachiko Tamogami
    Kenta Kojima
    Masakazu Satou
    Natsumi Yamashita
    Norihiro Teramoto
    Kenjiro Aogi
    Breast Cancer, 2016, 23 : 211 - 215
  • [29] Correlation of HER2 gene status assessment by fluorescence in situ hybridization between histological sections and cytological specimens of breast cancer
    Nishimura, Rieko
    Kagawa, Akihiro
    Tamogami, Sachiko
    Kojima, Kenta
    Satou, Masakazu
    Yamashita, Natsumi
    Teramoto, Norihiro
    Aogi, Kenjiro
    BREAST CANCER, 2016, 23 (02) : 211 - 215
  • [30] HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases
    Zhang, Han
    Ren, Guoping
    Wang, Xiaoling
    Zhao, Jing
    Yao, Hongtian
    Bai, Yanfeng
    Bo, Wang
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 743 - 749